Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

HPLC Determination and Steady-State Bioavailability Study of Levodropropizine Sustained-release Tablets in Dogs

  • Yan, Lin (Center For Drug Reevaluation, State Food and Drug Administration) ;
  • Li, Tongling (Division of Clinical Pharmacy, West China College of Pharmacy, Sichuan University) ;
  • Zhang, Rongqin (Division of Clinical Pharmacy, West China College of Pharmacy, Sichuan University) ;
  • Xu, Xiaohong (Division of Clinical Pharmacy, West China College of Pharmacy, Sichuan University) ;
  • Zheng, Pengcheng (Division of Clinical Pharmacy, West China College of Pharmacy, Sichuan University)
  • Published : 2006.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

A simple HPLC method using UV detection was developed and validated for the determination of levodropropizine (LDP) In dog plasma. The sample was prepared for injection using a liquid-liquid extraction method with 1-phenypiperazine as the internal standard. The mobile phase was methanol - diethylamine solution (0.05 M) (20:80, v/v, pH adjusted to 3.0 with $H_3PO_4$) with a detection wavelength of 240 nm. The limit of quantitation (LOQ) of LDP in a biological matrix was determined to be 25.25 ng/mL. The calibration curve was linear across the concentration range of 25.25 to 2020 ng/mL. The intra-day and inter-day precision values (CV%) were within 7% and accuracy (R.E. %) was within 6% of the nominal values for medium (252.5 ng/mL) and high (2020 ng/mL) LDP concentrations. For the LDP concentration at the LOQ, the intra-day and inter-day precision and accuracy were within 20% and 10%, respectively. The average absolute recovery for LDP was 70.28%. This method was successfully used to analyze plasma samples in a steady-state bioavailability study of a newly developed sustained-release LDP tablets (SR) using immediate-release tablets (IR) as the reference. The relative bioavailability of the SR was determined to be $106.3\;{\pm}\;12.8%$ (n=6). The $C_{max}$ of the SR was significantly lower (p<0.05), and the $t_{max}$ was significantly longer than that of the IR (p<0.05). The results of ANOVA and two one-sided tests indicated that the SR exhibited acceptable sustained release properties and was bioequivalent to the IR.

Keywords

References

  1. Borsa, M., Glavenna, G., Ferrari, M. P., Canali, S., Giachetti, C., and Zanolo, G., Linearity of levodropropizine, a new antitussive drug, in the healthy volunteer. Eur. J. Drug. Metab. Pharmacokinet., 3,178-184 (1991)
  2. Bressolle, F., Bromet-Petit, M., and Audran, M., Validation of liquid chromatographic and gas chromatographic methods applications to pharmacokinetics. J. Chromatogr. B Biomed. Appl., 686, 3-10 (1996 ) https://doi.org/10.1016/S0378-4347(96)00088-6
  3. Causon, R., Validation of chromatographic methods in biomedical analysis. Viewpoint and discussion. J. Chromatogr. B Biomed. Sci. Appl., 689, 175-180 (1997) https://doi.org/10.1016/S0378-4347(96)00297-6
  4. FDA, Guidance for Industry: Statistical Approaches to Establishing Bioequivalence. Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration, (1997)
  5. Hartmann, C., Smeyers-Verbeke, J., Massart, D. L., and McDowall, R. D., Validation of bioanalytical chromatographic methods. J. Pharm. Biomed. Anal., 17,193-218 (1998) https://doi.org/10.1016/S0731-7085(97)00198-2
  6. Hu, X. Z., Yu, J. X., and Lin, Y. F., Determination of levodropropizine in serum by tandem gas chromatographymass spectrometry. Analysis And Testing Technology Andinstruments, 6, 228-231 (2000)
  7. Malandrino, S., Melillo, G., Bestetti, A., Borsa, M., Giuliani, P., and Tonon, G. C., Antitussive properties of levodropropizine. Arzneimittelforschung., 38, 1141-1143 (1988)
  8. Melillo, G., Malandrino, S., Rossoni, G., Caselli, G., Bestetti, A., Borsa, M., Tonon, G. C., and Berti, F., General pharmacology of the new antitussive levodropropizine. Arzneimittelforschung., 38, 1144-1150 (1988)
  9. SFDA, Guidance: Bioavailability and Bioequivalence studies for drug products in human being. The State Food and Drug Administration of China, (2004)
  10. Tagliaro, F., Moffa, M., De Battisti, Z., Smith, F. P., and Gentile, M., High-performance liquid chromatographic determination of levodropropizine in human plasma with fluorometric detection. J. Chromatogr. B Biomed. Appl., 685, 165-170 (1996) https://doi.org/10.1016/0378-4347(96)00163-6
  11. Zaratin, P., De Angelis, L., and Cattabeni, F., Gas chromatographic- mass spectrometric determination of levodropropizine plasma levels in healthy volunteers. Arzneimittelforschung., 38, 1156-1158 (1988)